SCHEMBL19003405

SCHEMBL19003405

Cc1c(C(=O)c2ccc(O)c(O)c2)ccc(O)c1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.53
▸ PTGS2 P35354 2/20 0.49
▸ SIRT1 Q96EB6 1/20 0.49
▸ CA12 O43570 4/20 0.47
▸ CA1 P00915 4/20 0.47
▸ CA2 P00918 4/20 0.47
▸ CA7 P43166 4/20 0.47
▸ CA9 Q16790 4/20 0.47
▸ CA14 Q9ULX7 4/20 0.47
▸ KDM4E B2RXH2 4/20 0.47
▸ MAPT P10636 3/20 0.47
▸ GAA P10253 2/20 0.47
▸ POLB P06746 1/20 0.47
▸ CA4 P22748 1/20 0.47
▸ CA6 P23280 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ RECQL P46063 3/20 0.46
▸ DBH P09172 1/20 0.46
▸ XDH P47989 1/20 0.46
▸ SYNJ2 O15056 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17357499 0.87 HDAC1 (0.59) HDAC1PTGS2CA12CA1CA2
SCHEMBL30103853 0.83 HDAC1 (0.75) HDAC1PTGS2SIRT1CA12CA1
SCHEMBL5703332 0.83 HDAC1 (0.75) HDAC1PTGS2SIRT1CA12CA1
SCHEMBL19003626 0.82 HDAC1 (0.53) HDAC1PTGS2SIRT1CA12CA1
SCHEMBL1758415 0.80 HDAC1 (0.59) HDAC1PTGS2SIRT1CA12CA1
SCHEMBL23484907 0.79 HDAC1 (0.53) HDAC1PTGS2SIRT1CA12CA1
SCHEMBL9639982 0.77 SIRT1 (0.47) HDAC1PTGS2SIRT1CA12CA1
Methyl Protocatechuate SCHEMBL31206439 0.77 CA12 (0.66) PTGS2CA12CA1CA2CA7
SCHEMBL19763340 0.76 HDAC1 (0.76) HDAC1KDM4EMAPTPOLBL3MBTL1
SCHEMBL1758192 0.76 CA12 (0.68) PTGS2SIRT1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017106861-A1 COMPOSITIONS OF POLYHYDROXYLATED BENZOPHENONES AND METHODS OF TREATMENT OF NEURODEGENERATIVE DISORDERS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2017-06-22 — — WO disclosed
Send feedback